您的位置：首页 > 产品中心 > 68506-86-5， (±)-Vigabatrin
(±)-Vigabatrin
Vigabatrin
| 产品编号： | 4141366 |
| 规格： | United States Pharmacopeia (USP) Reference Standard |
| CAS NO： | 68506-86-5 |
| 包装规格： | 200 MG |
| 产品类别： | 进口试剂 |
| 品牌： | USP |
| 优惠价： | 立即咨询 |
产品价格查看更多规格...
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 4141366 | 200 MG | 4620 |
产品别名
68506-86-5
(±)-Vigabatrin
Vigabatrin
(±)-γ-Vinyl-GABA
(R,S)-4-Amino-5-hexenoic acid
(±)-4-Aminohexenoic acid
(±)-4-氨基己酸
(R,S)-4-氨基-5-己烯酸
(±)-γ-乙烯基-GABA
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C6H11NO2 |
| Molecular weight | 129.16 |
| MDL number | MFCD00274577 |
| PubChem Substance ID【PubChem化学物质编号】 | 329751497 |
| NACRES | NA.24 |
| General description【一般描述】 | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. |
| Biochem/physiol Actions【生化/生理作用】 | 不可逆的 GABA 转氨酶抑制剂。增加神经末梢的胞内 GABA 浓度；具有抗癫痫活性。 |
| Analysis Note【分析说明】 | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Other Notes【其他说明】 | USP issued SDS can be found here. Sales restrictions may apply. |
产品性质
| grade【等级】 | pharmaceutical primary standard |
| manufacturer/tradename | USP |
| application(s) | pharmaceutical (small molecule) |
| format【格式】 | neat |
| SMILES string | NC(CCC(O)=O)C=C |
| InChI | 1S/C6H11NO2/c1-2-5(7)3-4-6(8)9/h2,5H,1,3-4,7H2,(H,8,9) |
| InChI key | PJDFLNIOAUIZSL-UHFFFAOYSA-N |
| Gene Information | human ... ABAT(18) |
安全信息
| Pictograms【象形图】 | GHS08 |
| Signal word【警示用语：】 | Danger |
| Hazard Statements | H372 |
| Precautionary Statements | P260 - P264 - P270 - P314 - P501 |
| Hazard Classifications【危险分类】 | STOT RE 1 |
| Storage Class Code【储存分类代码】 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| WGK | WGK 1 |
